EVO ICL™ Surgery

The vision correction specialists at Skyline LASIK offer a range of vision correction solutions, allowing us to customize each patient’s experience according to their unique needs, refractive errors, and lifestyle. We are proud to offer our patients from the Colorado Springs, CO area advanced refractive surgery with the EVO ICL lens, an innovative vision correction procedure that may free patients with nearsightedness and astigmatism from the hassle of glasses and contact lenses.

FIND OUT IF EVO IS RIGHT FOR YOU!

EVO ICL™

Skyline LASIK is dedicated to providing patients exceptional vision solutions and personalized experience. Our approach allows us to tailor the best  vision correction surgery for each patient, considering their unique needs, refractive errors, and lifestyle. We are proud to offer patients EVO ICL as a vision correction solution in Colorado Springs. This innovative procedure performed by Dr. Matthew Chang is designed to treat moderate to severe nearsightedness (myopia), with or without astigmatism.

Who is a Good Candidate for EVO ICL?

Candidates for EVO ICL:

  • Are between the ages of 21- 45
  • Have moderate to severe nearsightedness (myopia) with or without astigmatism
  • Have a stable prescription and overall healthy eyes 
  • Are less suited for laser vision correction procedures like  LASIK & PRK
quote from Actor Peyton List about her EVO ICL experience

Before your EVO ICL consultation, please discontinue wearing contact lenses, which can alter the shape of your cornea.

  • Hard contacts (RGP, Scleral) for at least 2 weeks 
  • Soft contacts (Monthly, Dailies, etc) for at least 3-5 days 

In the days leading up to your surgery, you’ll need to pick up your prescribed medicated eye drops your surgeon sent to your local pharmacy and make arrangements for transportation to and from the surgery center (you won’t be permitted to drive yourself home).

The day of your EVO ICL surgery, do not eat or drink 8 hours prior to arriving  and should not wear contacts lenses, makeup, lotions, perfumes or jewelry to the surgery center.

Recovery After EVO ICL

You won’t need much downtime after your EVO ICL surgery: the majority of our patients go back to work or school the very next day. You might experience some mild discomfort in the first few days after your surgery, but this will be easily managed with over-the-counter medication and a cool compress. Please be sure to adhere to all of Dr. Chang’s instructions regarding prescribed antibiotics and anti-inflammatory eye drops. It’s important to keep all post operative appointments after surgery so we can monitor your recovery. One of the best things about EVO ICL is how quickly it works: you will notice a significant improvement in your vision nearly immediately!

“Dr. Chang and the whole Skyline LASIK group are phenomenal, you can tell they care about their patients. If you’ve done your research you already know they are the best in CO Springs!

I had the ICL surgery, and they briefed me on what to expect, timelines to expect it, etc. A few moments of discomfort for 20/15 vision, my only regret is I didn’t make the decision sooner.”

Michael P., Google Business Review

Frequently Asked Questions About EVO ICL

Is EVO ICL surgery painful?

No. You will be given IV sedation along with anesthetic eye drops before your surgery, so you should not feel any pain.

Will other people be able to see the EVO ICL in my eye?

No. Nobody will be able to notice the EVO ICL in your eye, and unlike a contact lens, you will not feel it.

Is EVO ICL safe?

EVO ICL is FDA-approved and is considered to be both safe and highly effective. The best way to ensure optimal vision correction surgery results is to work with an experienced ophthalmologist like Dr. Matthew Chang.

Is the EVO ICL lens permanent?

EVO ICL is designed to provide permanent vision correction in patients who have myopia (nearsightedness) with or without astigmatism. However, one benefit of EVO ICL is that it can be removed if a patient’s needs change, which offers our patients the only reversible surgical option to correct their vision and the flexibility for their future.

It is important to note that, while EVO ICL can correct a patient’s current vision, it can not prevent changes to the eye that are a part of the natural aging process. Patients may still require reading glasses to help with age-related near vision loss called presbyopia, which begins to affect everyone in their 40’s.

1 Martínez-Plaza E, López-Miguel A, López-de la Rosa  A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. Available: https://pubmed.ncbi.nlm.nih.gov/33577790/. Accessed September 6, 2023.

2  Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53. Available: https://pubmed.ncbi.nlm.nih.gov/35645557/. Accessed September 6, 2023.

3  Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215. Available: https://pubmed.ncbi.nlm.nih.gov/27418804/. Accessed September 6, 2023.

4  Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438. Available: https://pubmed.ncbi.nlm.nih.gov/30568421/. Accessed September 6, 2023.

5  Parkhurst GD, Psolka M, Kezirian GM. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481. Available: https://pubmed.ncbi.nlm.nih.gov/21243974/. Accessed September 6, 2023.

6 Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263. Available: https://pubmed.ncbi.nlm.nih.gov/28740361/. Accessed September 6, 2023.